Diet and Progression of CKD in Patients With Type 2 Diabetes Mellitus
NCT07169786 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 160
Last updated 2025-09-12
Summary
The aim of this study is to investigate the relationship between dietary patterns and the progression of chronic kidney disease (CKD) in patients with type 2 diabetes mellitus.
Conditions
- CKD Stage 1-4
- Diet Pattern Analysis
- Type2 Diabetes Mellitus
Sponsors & Collaborators
-
Mariam Emeel Haleem Naseem
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-31
- Primary Completion
- 2028-10-31
- Completion
- 2028-12-31
More Related Trials
-
The Expression of circANKRD36 as a New Biomarker of Diabetic Nephropathy
NCT05061459 ·Status: UNKNOWN
-
Therapeutic Drug Use for CKD Patients
NCT05818995 ·Status: UNKNOWN
-
Evaluating The Roles of Novel Inflammatory Markers Compared to MCP-1 in Type 2 Diabetic Nephropathy
NCT07173686 ·Status: NOT_YET_RECRUITING
-
Association of AGTR1 and ACACB Gene Polymorphism and Diabetic Nephropathy in Type 2 Diabetes
NCT01069549 ·Status: COMPLETED
-
Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD
NCT06069076 ·Status: NOT_YET_RECRUITING
-
Lipid Profile in Diabetic and Non Diabetic CKD Patients
NCT06802978 ·Status: RECRUITING
-
Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease
NCT05373004 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study to Learn More About Chronic Kidney Disease (CKD) in Patients With Type 2 Diabetes Mellitus (T2DM)
NCT05004428 ·Status: COMPLETED
-
Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
NCT07116928 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Nitric Oxide (NO) Activity and Diabetic Nephropathy
NCT00136188 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Influence of the Thickening of Bowman's Capsule on the Clinical Prognosis of Patients With Diabetic Kidney Disease
NCT06049550 ·Status: UNKNOWN
-
An Investigation on the Effect of Candesartan on Early Diabetic Nephropathy
NCT01273675 ·Status: UNKNOWN
-
A Study Using the LMC Diabetes Registry to Learn More About Chronic Kidney Disease (CKD) in Canadian Patients With Type 2 Diabetes (T2D)
NCT04445181 ·Status: COMPLETED
-
Efficacity and Safety of Metformin XR in CKD Stage 1 to 3
NCT02895750 ·Status: COMPLETED ·Phase: PHASE2
-
Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy
NCT00253786 ·Status: COMPLETED ·Phase: NA
-
Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting.
NCT02194790 ·Status: COMPLETED ·Phase: NA
-
A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 Diabetes
NCT01500798 ·Status: TERMINATED ·Phase: PHASE1
-
A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
NCT01572610 ·Status: TERMINATED ·Phase: PHASE2
-
An Observational, Cross Sectional Study to Assess the Prevalence of Chronic Kidney Disease (CKD) in Type 2 Diabetes Patients
NCT02208921 ·Status: COMPLETED
-
Preliminary Study of CXCL3 As a Biomarker of Diabetic Kidney Disease
NCT06639529 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Shenyankangfu Tablets for Chronic Kidney Disease
NCT02885857 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes
NCT06532682 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Clinical Study to Evaluate the Food Effect of CKD-383 0.5/25/1000mg in Healthy Volunteers
NCT06695598 ·Status: COMPLETED ·Phase: PHASE1
-
The Differential Effects of Diabetes Therapy on Inflammation
NCT02150707 ·Status: COMPLETED
-
Risk of CKD in Diabetic Patients With MAFLD
NCT06304844 ·Status: NOT_YET_RECRUITING